Dr. Richard L Huganir's lab at Johns Hopkins University focuses on understanding how the brain encodes memories through the study of AMPA receptors, which are crucial for synaptic transmission and plasticity. The lab uses innovative techniques such as two-photon microscopy and biotinylation to visualize and analyze the interactions of synaptic proteins during learning and memory processes in live mice. Their research aims to uncover the molecular mechanisms underlying various brain disorders and to identify potential therapeutic targets for conditions like Alzheimer's, schizophrenia, and autism.

Dr. Solange P Brown's lab at Johns Hopkins University studies how a brain region called the claustrum helps us make flexible decisions, especially under changing circumstances. They use animal models to investigate how the claustrum interacts with other brain areas critical for cognition, particularly when we need to learn from our past choices. By understanding these brain mechanisms better, the research aims to shed light on cognitive flexibility, which is often impaired in various neuropsychiatric disorders like schizophrenia and ADHD.

Dr. Shanshan Jiang's lab at Johns Hopkins University focuses on improving the diagnosis and treatment monitoring of glioblastoma, a highly aggressive brain tumor. The research combines innovative liquid biopsy techniques, analyzing circulating tumor DNA, with advanced MRI imaging to provide real-time insights into how well patients are responding to treatment. This work aims to develop non-invasive methods that could spare many patients from unnecessary surgeries and lead to more personalized treatment strategies.

Dr. James J. Knierim's lab explores the role of the hippocampus in learning and memory, particularly how its function may change with aging and in conditions like Alzheimer's disease. Using rodent models, the lab studies how different parts of the hippocampus contribute to memory processing and how age-related changes impact cognitive functions. Their research aims to uncover mechanisms underlying memory deficits to help develop potential therapeutic interventions for age-related cognitive decline.

Dr. James M. Berger's lab at Johns Hopkins University is focused on studying DNA topoisomerases, which are proteins that help manage the structure of DNA. This research is particularly important for understanding cancer development and treatment, as these proteins are crucial drug targets for cancer therapy. The lab combines various approaches, including biochemical and computational techniques, to explore how these enzymes contribute to genome stability and how drugs can be improved to better combat cancer.

Dr. Sridhar Nimmagadda's lab focuses on improving the diagnosis and treatment of blood cancers like multiple myeloma and lung cancer through innovative theranostic approaches. They aim to create advanced imaging agents and targeted therapies that can effectively measure and combat cancer while reducing the need for invasive procedures. By developing new, easy-to-use radiopharmaceuticals, the lab seeks to enhance the precision of immunotherapy treatments and improve patient outcomes.

Dr. Jeff W. Bulte's lab at Johns Hopkins University focuses on improving cancer treatments through advanced imaging technologies. By using magnetic iron oxide nanoparticles (MIONPs), the lab works on coordinating imaging with magnetic fluid hyperthermia (MFH) to enhance the effectiveness of radiation therapy for cancer patients. The goal is to develop methods that allow precise control of heat applied to tumors while monitoring the treatment in real-time, which could lead to better outcomes for patients.

Dr. David L. Thomas's lab at Johns Hopkins University focuses on understanding liver diseases, particularly hepatitis C (HCV) and steatotic liver disease, especially in people who inject drugs and those living with HIV. The lab investigates the causes and trends of these diseases, aiming to inform public health policies and improve treatment outcomes. Through this research, the lab seeks to address the growing health crisis related to liver disease in vulnerable populations.

Dr. Natalia A. Trayanova's lab focuses on advancing strategies for diagnosing and treating heart rhythm disorders using innovative technologies like digital twins and artificial intelligence. By understanding how conditions like obesity affect heart health and arrhythmias, the lab aims to develop personalized approaches to improve therapies for patients suffering from ventricular arrhythmias and atrial fibrillation. Their work bridges computational modeling with clinical applications, making strides towards more effective treatments and interventions.

Dr. Sergi Regot's lab at Johns Hopkins University focuses on cancer research, particularly how certain genetic changes within tumors can affect cancer growth and response to treatment. They are exploring a protein called TRIM37 and its role in making some cancer cells more vulnerable to specific therapies that target a protein involved in cell division. The aim is to find new ways to treat aggressive cancers, such as breast cancer and neuroblastoma, that show genetic alterations.

Dr. Kyrana Tsapkini's lab focuses on developing innovative treatments for language impairments associated with atypical Alzheimer's disease, particularly in patients suffering from logopenic variant primary progressive aphasia (lvPPA). Using a method called transcranial direct current stimulation (tDCS), they aim to enhance the effectiveness of speech-language therapy and improve cognitive functions like memory. Their research explores how targeted brain stimulation can help mitigate cognitive deficits and generalize language treatment benefits for those affected by this condition.

The Tsukamoto Lab at Johns Hopkins University is focused on developing new treatments for Alzheimer's disease by targeting an enzyme called neutral sphingomyelinase 2 (nSMase2). This research aims to inhibit the production of harmful molecules that contribute to Alzheimer's pathology, potentially slowing the disease's progression. By optimizing new drug candidates and testing them in animal models, the lab hopes to find effective therapies that can improve outcomes for patients suffering from Alzheimer's.

Dr. Rebecca Terilli Veenhuis leads a research lab at Johns Hopkins University focusing on understanding how HIV and cocaine use disorder affect the blood-brain barrier and cognitive function. Her team explores immune mechanisms that govern brain health, particularly how immune cells associated with HIV can disrupt the protective barrier and contribute to cognitive impairment. The lab employs advanced imaging techniques and animal models to investigate novel treatments aimed at reducing inflammation and improving cognitive outcomes in people living with HIV.

Dr. Xiaoqin Wang's lab at Johns Hopkins University focuses on developing tools for gene editing in marmosets, which are small primates that can serve as valuable models for studying human brain diseases. The lab works on refining genetic manipulation techniques to create genetically modified marmosets that can help us understand brain function and neurobiology. By establishing a colony of marmosets and employing advanced genetic technologies, the research aims to generate innovative models that could pave the way for new therapies for brain-related disorders.

Dr. Ashani T Weeraratna's lab focuses on understanding how aging affects melanoma, particularly the way dormant cancer cells can reactivate and spread. The research examines how aged tissues impact tumor behavior and treatment resistance through specific signaling pathways. This work aims to identify new strategies to prevent cancer recurrence, especially in older patients, enhancing the effectiveness of existing therapies.

Dr. Denis Wirtz's lab at Johns Hopkins University focuses on improving cancer therapies, especially for pancreatic cancer, using advanced engineering techniques. The research centers on enhancing the movement and effectiveness of CAR T cells, which are immune cells engineered to target and destroy cancer. By creating synthetic receptors that boost how quickly these cells can migrate into tumors, the lab aims to increase treatment success rates for solid tumors, which are notoriously challenging to treat.

Dr. Guang William Wong's lab at Johns Hopkins University focuses on understanding how certain hormones impact liver fat metabolism. They study CTRP1, a hormone that helps regulate fat storage and utilization in the liver and adipose tissue. By using mouse models to investigate the mechanisms behind CTRP1's action, the lab aims to uncover new strategies to combat diseases like non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Dr. Laura Delong Wood's lab at Johns Hopkins University focuses on understanding how precancerous lesions in the pancreas evolve into cancer. By analyzing the genetics of these lesions and using advanced computational techniques, the lab aims to uncover the processes that lead to pancreatic cancer. This research hopes to pave the way for better early detection and treatment of pancreatic cancer by revealing crucial insights into its development.

Dr. Sarah A. Woodson's lab at Johns Hopkins focuses on understanding how non-coding RNAs, which play a crucial role in gene expression, assemble with proteins to form complexes that regulate biological processes. The lab employs advanced techniques, including single molecule fluorescence microscopy, to investigate these interactions in live cells and model systems like bacteria and yeast. The ultimate goal is to uncover the physical principles behind RNA-protein assembly that can inform therapeutic strategies for diseases linked to non-coding RNAs.

Dr. Carl Wu's lab at Johns Hopkins University focuses on understanding how genes are expressed in living cells by studying the processes that regulate chromatin, the structure that organizes DNA. They use advanced techniques to visualize how proteins interact with DNA and regulate gene activity, particularly under stress conditions like heat. The lab aims to uncover the precise timing and mechanics of these processes to enhance our understanding of gene regulation and its implications for various biological functions.